Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BioNTech

Cancer vaccine trials could start in the autumn – UK signs deal with BioNTech

The UK government recently announced that it is partnering with German firm BioNTech to test vaccines for cancer and other diseases. The project aims to build on the mRNA vaccine technology that BioNTech became famous for developing, and which has been so successful at preventing serious illness and death from…

The Conversation

Plan for mRNA cancer vaccine trials to start in United Kingdom this year

Plan for mRNA cancer vaccine trials to start in United Kingdom this year

Personalised cancer vaccine trials in England will roll out this year after the United Kingdom government signed a deal with a company behind one of the major COVID-19 vaccines.

Chinese Mainlanders Can Book Omicron-Specific mRNA Shot in Hong Kong

Chinese Mainlanders Can Book Omicron-Specific mRNA Shot in Hong Kong

Fosun Pharma opens online reservation platform for BioNTech vaccination as Covid border controls are set to end

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

UK signs groundbreaking mRNA cancer vaccine research agreement

The partnership with German pharmaceutical company BioNTech will be one of the first of its kind

Evening Standard

UK speeds up plans to develop mRNA vaccines for cancer patients with BioNTech deal

Deal follows UK’s largely successful Covid vaccine roll out

The Independent UK

Cancer vaccine trials could start in England by autumn

Government deal with BioNTech paves way for early access to trials of personalised mRNA therapies

The Guardian - UK

BioNTech signs deal with UK for personalised cancer therapies

BioNTech SE has signed a deal with the UK government to enrol up to 10,000 patients in clinical trials by the end of 2030 for personalised cancer therapies, the German drug maker said.

inkl

Read news from The Economist, FT, and more,
with one subscription

UK Health Secretary to sign cancer treatments deal for patients in England

UK Health Secretary to sign cancer treatments deal for patients in England

Steve Barclay is set to sign a memorandum of understanding with BioNTech to ensure high quality cancer treatments are available as soon as possible

Health Secretary to sign cancer treatments deal with leading pharmaceutical company

Health Secretary to sign cancer treatments deal with leading pharmaceutical company

Steve Barclay is due to sign a memorandum of understanding with BioNTech on Friday.

The Independent UK

Here are the 5 biggest innovations to expect in 2023

Here are the 5 biggest innovations to expect in 2023

Inverse predicts the biggest innovations of 2023, including wins in renewable energy, electric vehicles, and biotechnology.

German expats in China receive first foreign COVID vaccines

German expats in China receive first foreign COVID vaccines

Germans living in China began receiving the BioNTech COVID-19 vaccine on Thursday, the first such rollout of a foreign coronavirus vaccine in a country that has not otherwise approved the use of non-Chinese vaccines even as infections soar.

Hong Kong residents rush to get vaccinated ahead of China border reopening

Hong Kong residents rush to get vaccinated ahead of China border reopening

Hong Kong residents have swamped clinics to get vaccinated against COVID-19 ahead of the expected reopening of the city's border with mainland China, which some people fear will bring a surge of infections to the financial hub.

Top Stories of the Month: Covid Chaos at China’s Hospitals as Stringent Control Policy Eases

Top Stories of the Month: Covid Chaos at China’s Hospitals as Stringent Control Policy Eases

Health care centers from Guangzhou to Shijiazhuang and Beijing are slammed amid surging infections and severe shortages of medical workers

Tests start for herpes vaccine

Tests start for herpes vaccine

BioNTech, which helped develop one of the early COVID-19 vaccinations, is working on a herpes simplex virus vaccine

Get all your
news in one place.

100’s of premium titles.
One news app.

Fosun app lets China users get BioNTech COVID vaccines in Hong Kong

China's Shanghai Fosun Pharmaceutical Group said users of its mobile health app in China can now register to take COVID-19 booster shots in Hong Kong using BioNTech's vaccine.

First foreign COVID vaccines head to China from Germany

Berlin has sent its first batch of BioNTech COVID-19 vaccines to China to be administered initially to German expatriates, a German government spokesperson said on Wednesday, the first foreign coronavirus vaccine to be delivered to the country.

Germany should help China-EU ties develop 'not subject to third party' -Xi

China and Germany should work together to foster good relations between Beijing and the European Union without any interference by a third party, President Xi Jinping told Germany's president in a phone call on Tuesday, state media reported.

The world fears a new China COVID wave, ponders how to help Xi

Officials and global health experts outside China are anxiously watching a COVID-19 surge there, worried a nation of 1.4 billion people is inadequately vaccinated and may not have the healthcare tools to treat a wave of illness expected to kill more than one million people through 2023.

Get all your
news in one place.

100’s of premium titles.
One news app.

China finally approves an mRNA COVID vaccine—but only for some foreigners

Beijing's uneasy relationship with mRNA vaccines is all the more relevant as it begins to relax COVID restrictions.

China to allow German expats to use German COVID-19 vaccines

The Chinese foreign ministry said China and Germany had reached an agreement on providing "German vaccines" to German nationals in China, after the German Chancellor recently said that BioNTech's COVID-19 vaccine would be used by German expatriates.

Work starts on nation-first mRNA facility

Biotech giant Moderna's first mRNA vaccine facility in Australia is due to open in 2024, and will produce 100 million vaccine doses per year.

Evening Standard

Covid: UK health regulator backs Pfizer/BioNTech vaccine for babies as young as six months

The move opens the door to vaccinating the country’s youngest children should the Joint Committee on Vaccination and Immunisation agree

Fauci: China's less-effective vaccines are stopping it from exiting COVID-zero

But a bigger problem for Beijing may be the number of elderly Chinese who have yet to get their booster shots.

Pfizer/BioNTech's updated COVID shot shows strong response against BQ.1.1

Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.

Weekly Must-Read: Battle Begins for China’s Private Pension Funds

Institutions are rushing to bring investment products to market in wake of government plan to grow the underdeveloped sector

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Monash University

Medicines and Healthcare products Regulatory Agency

Crispr rapeutics

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

124,795 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play